Synaptogenix Inc (SNPX)

[SF Wolf]

"The LT shareholers are lined up to sell on results" what proof do you have to back up that statement?

The private placement investors that I personally know have a very different game plan and it does not involve selling out of their investment if the Ph2b results upend the entire AD research field.

A new paradigm for AD treatment, one that works, is going to be worth significantly more than the initial run-up in stock price. It will take time for the true market valuation to be revealed, most likely by a Big Pharma partner or outright buyout.